|
|
Volumn 33, Issue 3, 2011, Pages 473-474
|
|
Mechanism based medicine in infancy: Complex interplay between developmental pharmacology and pharmacogenetics
|
|
Author keywords
CYP2D6; Developmental pharmacology; Pharmacogenetics; Tailored pharmacotherapy; Tramadol
|
|
Indexed keywords
CYTOCHROME P450 2D6;
O NORTRAMADOL;
PAROXETINE;
TRAMADOL;
AGE;
CLINICAL PHARMACOLOGY;
COMPETITIVE INHIBITION;
DEVELOPMENTAL PHARMACOLOGY;
DOSE RESPONSE;
DRUG BLOOD LEVEL;
DRUG CLEARANCE;
DRUG DISPOSITION;
DRUG ELIMINATION;
DRUG METABOLISM;
DRUG URINE LEVEL;
ENZYME ACTIVITY;
ENZYME POLYMORPHISM;
EVIDENCE BASED MEDICINE;
HUMAN;
KIDNEY CLEARANCE;
MYDRIASIS;
PAIN;
PEDIATRICS;
PERSONALIZED MEDICINE;
PHARMACOGENETICS;
PHARMACOLOGICAL SCIENCE;
PHENOTYPIC VARIATION;
PRIORITY JOURNAL;
REVIEW;
AGE FACTORS;
CYTOCHROME P-450 CYP2D6;
HUMANS;
INFANT;
METABOLIC CLEARANCE RATE;
PHARMACEUTICAL PREPARATIONS;
PHARMACOGENETICS;
|
|
EID: 79960043777
PISSN: 22107703
EISSN: None
Source Type: Journal
DOI: 10.1007/s11096-011-9504-3 Document Type: Review |
|
Times cited : (6)
|
|
References (5)
|
